Page last updated: 2024-10-31

metoclopramide and Hyperaldosteronism

metoclopramide has been researched along with Hyperaldosteronism in 28 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Hyperaldosteronism: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.

Research Excerpts

ExcerptRelevanceReference
"Cosyntropin and metoclopramide can affect the subtyping of primary aldosteronism when used with adrenal vein sampling by exerting hormone- and side-specific effects on cortisol and aldosterone secretion."7.88Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide. ( Bisogni, V; Cesari, M; Iacobone, M; Lenzini, L; Maiolino, G; Rossi, GP; Rossitto, G; Seccia, TM, 2018)
"As metoclopramide stimulates aldosterone secretion, we tested its usefulness in the assessment of lateralization of primary aldosteronism by adrenal vein sampling (AVS)."7.83Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism. ( Barbiero, G; Battistel, M; Bisogni, V; Maiolino, G; Miotto, D; Rossi, GP; Rossitto, G; Sanga, V, 2016)
"Approximately half of Caucasian patients with essential hypertension and with hyperaldosteronism exhibit elevated circulating levels of endogenous ouabain."7.69Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. ( De Toni, R; Hamlyn, JM; Manunta, P; Pavan, E; Pessina, AC; Rossi, G; Semplicini, A, 1995)
"To examine the previous suggestion that the endogenous dopaminergic activity would be increased in patients with primary aldosteronism, dose-response curves of aldosterone and prolactin stimulation by the dopamine antagonist metoclopramide were established in a pilot study by injecting metoclopramide 1, 2."7.67Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism. ( Althoff, PH; Jungmann, E; Rosak, C; Schöffling, K; Schwedes, U, 1986)
"Plasma aldosterone, 18-hydroxycorticosterone (18-OH-B), 18-hydroxydeoxycorticosterone (18-OH-DOC), corticosterone, cortisol and prolactin levels were determined during an angiotensin II infusion at increasing rates both with and without a simultaneous infusion of dopamine in seven normotensive subjects, in ten patients with essential hypertension, and in ten patients with primary aldosteronism."7.67Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. ( Lorenz, R; von Werder, K; Weber, PC; Witzgall, H, 1985)
"To investigate possible dopaminergic effects on aldosterone production, we administered the dopamine antagonist metoclopramide to 11 normal subjects, 8 patients with primary aldosteronism due to adenoma or hyperplasia, and 5 other patients with the glucocorticoid-suppressible form of hyperaldosteronism (GSH)."7.66Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism. ( Fineberg, NS; Ganguly, A; Grim, CE; Pratt, JH; Weinberger, MH, 1983)
"To assess the interaction between dopamine and aldosterone secretion in primary aldosteronism, the dopamine antagonist, metoclopramide (methoxy-2-chloro-5-procainamide), was given as an i."7.66Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism. ( Fukuchi, S; Hashimoto, S; Ikeda, K; Mizuno, K; Yaginuma, K; Yamazaki, M, 1983)
"Plasma mineralocorticoid and prolactin levels were evaluated before and 15, 30, 60 and 120 min after the administration of 10 mg metoclopramide in seven normotensive volunteers (42 +/- 5 (SD) years), as well as in ten patients with primary aldosteronism five with aldosterone-producing adenoma (49 +/- 4), and five with bilateral hyperplasia (47 +/- 3)."7.66Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism. ( von Werder, K; Weber, PC; Witzgall, H, 1983)
"The behaviour of plasma renin, aldosterone, cortisol and prolactin after administration of a drug with antidopaminergic action, metoclopramide, was evaluated in 6 normal subjects, 8 patients affected by primary aldosteronism and in 5 patients affected by anterior hypopituitarism."7.66Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism. ( Armanini, D; Boscaro, M; Fallo, F; Mantero, F; Opocher, G; Valpione, E, 1981)
"Cosyntropin and metoclopramide can affect the subtyping of primary aldosteronism when used with adrenal vein sampling by exerting hormone- and side-specific effects on cortisol and aldosterone secretion."3.88Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide. ( Bisogni, V; Cesari, M; Iacobone, M; Lenzini, L; Maiolino, G; Rossi, GP; Rossitto, G; Seccia, TM, 2018)
"As metoclopramide stimulates aldosterone secretion, we tested its usefulness in the assessment of lateralization of primary aldosteronism by adrenal vein sampling (AVS)."3.83Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism. ( Barbiero, G; Battistel, M; Bisogni, V; Maiolino, G; Miotto, D; Rossi, GP; Rossitto, G; Sanga, V, 2016)
"To investigate the possible role of dopamine, a catecholamine with natriuretic properties, in modulating the escape from the sodium-retaining effects of mineralocorticoids, we submitted six aldosterone-producing adenoma (APA) patients and six low-renin essential hypertensive patients to acute volume expansion by head-out water immersion with or without dopaminergic blockade by metoclopramide."3.69Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine? ( Coruzzi, P, 1994)
"Approximately half of Caucasian patients with essential hypertension and with hyperaldosteronism exhibit elevated circulating levels of endogenous ouabain."3.69Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. ( De Toni, R; Hamlyn, JM; Manunta, P; Pavan, E; Pessina, AC; Rossi, G; Semplicini, A, 1995)
"Hyperresponsiveness of plasma aldosterone to metoclopramide (MCP) was found in the patients with secondary aldosteronism."3.67[Influence of endogenous renin-angiotensin system on plasma aldosterone responsiveness to metoclopramide]. ( Iwasaki, Y, 1987)
"To examine the previous suggestion that the endogenous dopaminergic activity would be increased in patients with primary aldosteronism, dose-response curves of aldosterone and prolactin stimulation by the dopamine antagonist metoclopramide were established in a pilot study by injecting metoclopramide 1, 2."3.67Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism. ( Althoff, PH; Jungmann, E; Rosak, C; Schöffling, K; Schwedes, U, 1986)
"Plasma aldosterone, 18-hydroxycorticosterone (18-OH-B), 18-hydroxydeoxycorticosterone (18-OH-DOC), corticosterone, cortisol and prolactin levels were determined during an angiotensin II infusion at increasing rates both with and without a simultaneous infusion of dopamine in seven normotensive subjects, in ten patients with essential hypertension, and in ten patients with primary aldosteronism."3.67Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. ( Lorenz, R; von Werder, K; Weber, PC; Witzgall, H, 1985)
"To assess the interaction between dopamine and aldosterone secretion in primary aldosteronism, the dopamine antagonist, metoclopramide (methoxy-2-chloro-5-procainamide), was given as an i."3.66Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism. ( Fukuchi, S; Hashimoto, S; Ikeda, K; Mizuno, K; Yaginuma, K; Yamazaki, M, 1983)
"Plasma mineralocorticoid and prolactin levels were evaluated before and 15, 30, 60 and 120 min after the administration of 10 mg metoclopramide in seven normotensive volunteers (42 +/- 5 (SD) years), as well as in ten patients with primary aldosteronism five with aldosterone-producing adenoma (49 +/- 4), and five with bilateral hyperplasia (47 +/- 3)."3.66Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism. ( von Werder, K; Weber, PC; Witzgall, H, 1983)
"The behaviour of plasma renin, aldosterone, cortisol and prolactin after administration of a drug with antidopaminergic action, metoclopramide, was evaluated in 6 normal subjects, 8 patients affected by primary aldosteronism and in 5 patients affected by anterior hypopituitarism."3.66Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism. ( Armanini, D; Boscaro, M; Fallo, F; Mantero, F; Opocher, G; Valpione, E, 1981)

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-199018 (64.29)18.7374
1990's5 (17.86)18.2507
2000's2 (7.14)29.6817
2010's3 (10.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rossitto, G2
Maiolino, G2
Lenzini, L1
Bisogni, V2
Seccia, TM2
Cesari, M1
Iacobone, M1
Rossi, GP3
Miotto, D2
Battistel, M1
Barbiero, G1
Sanga, V1
De Toni, R2
Gallina, V1
Vincenzi, M1
Pessina, AC2
Wu, KD2
Chen, YM2
Chu, TS2
Chueh, SC1
Tsai, GC1
Tseng, YZ1
Hsieh, BS2
Mizuno, K2
Yaginuma, K2
Yamazaki, M2
Fukuchi, S2
Ganguly, A1
Pratt, JH1
Weinberger, MH2
Grim, CE1
Fineberg, NS1
Ikeda, K1
Hashimoto, S1
Shimizu, Y2
Hanew, K1
Sato, S1
Sasaki, A1
Murakami, O1
Yoshinaga, K1
Witzgall, H3
von Werder, K2
Weber, PC3
Müller, OA1
Mazzacca, G1
D'Arienzo, A1
Ambrogio, G1
Słowińska-Srzednicka, J1
Zgliczyński, S1
Mantero, F1
Opocher, G1
Boscaro, M1
Valpione, E1
Armanini, D1
Fallo, F1
Gniadek, TC1
Grekin, RJ1
Gross, MD1
Villareal, JZ1
Fanning, S1
Ishisaka, DY1
Merritt, TA1
Coruzzi, P1
Mune, T1
Morita, H1
Yasuda, K1
Yamakita, N1
Miura, K1
Naruse, M1
Naruse, K1
Yoshimoto, T1
Tanaka, M1
Tanabe, A1
Imaki, T1
Shibasaki, T1
Demura, R1
Demura, H1
Rossi, G1
Manunta, P1
Hamlyn, JM1
Pavan, E1
Semplicini, A1
Liao, TS1
Lai, MK1
Chen, SJ1
Su, CT1
Chang, CC1
Brown, RD1
Wisgerhof, M1
Carpenter, PC1
Brown, G1
Jiang, NS1
Kao, P1
Hegstad, R1
Carey, RM1
Sen, S1
Iwasaki, Y1
Jungmann, E1
Althoff, PH1
Rosak, C1
Schwedes, U1
Schöffling, K1
Lorenz, R1
Yanase, T1
Nawata, H1
Higuchi, K1
Kato, K1
Ibayashi, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale andDesign of A Randomized Study (I-PADUA)[NCT03449797]200 participants (Anticipated)Interventional2018-04-01Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for metoclopramide and Hyperaldosteronism

ArticleYear
Recent progress in the control of aldosterone secretion.
    Recent progress in hormone research, 1986, Volume: 42

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Blood Pressure; Blood Proteins; D

1986

Trials

2 trials available for metoclopramide and Hyperaldosteronism

ArticleYear
[Hyperaldosteronism after metoclopramide administration].
    Polskie Archiwum Medycyny Wewnetrznej, 1980, Volume: 64, Issue:1

    Topics: Adult; Aldosterone; Clinical Trials as Topic; Female; Humans; Hyperaldosteronism; Male; Metocloprami

1980
Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
    Hypertension research : official journal of the Japanese Society of Hypertension, 1995, Volume: 18 Suppl 1

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Dopamine; Dopamine Antagonists; Female;

1995

Other Studies

25 other studies available for metoclopramide and Hyperaldosteronism

ArticleYear
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide.
    Surgery, 2018, Volume: 163, Issue:4

    Topics: Adrenal Glands; Adult; Aged; Biomarkers; Cosyntropin; Dopamine D2 Receptor Antagonists; Female; Horm

2018
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism.
    Journal of hypertension, 2016, Volume: 34, Issue:11

    Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Male; Metoclopramide; Middle Aged; Prospective Stud

2016
Subtyping of primary aldosteronism by adrenal vein sampling: effect of acute D(2) receptor dopaminergic blockade on adrenal vein cortisol and chromogranin A levels.
    European journal of endocrinology, 2011, Volume: 165, Issue:1

    Topics: Adrenal Glands; Adult; Aldosterone; Chromogranin A; Dopamine D2 Receptor Antagonists; Female; Humans

2011
Dopaminergic modulation of aldosterone secretions on changes of sodium intake in aldosterone-producing adenoma.
    American journal of hypertension, 2002, Volume: 15, Issue:7 Pt 1

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; Diet, Sodium-R

2002
[The effect of metoclopramide, a dopamine inhibitor, on aldosterone secretion in patients with primary aldosteronism].
    Nihon Naibunpi Gakkai zasshi, 1982, Aug-20, Volume: 58, Issue:8

    Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Dexamethasone; Dopamine; Female; Humans; Hydrocorti

1982
Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
    The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:2

    Topics: Adrenocorticotropic Hormone; Aldosterone; Dexamethasone; Glucocorticoids; Humans; Hydrocortisone; Hy

1983
Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Japanese heart journal, 1983, Volume: 24, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Dexamethasone; Female; Humans; Hydrocortisone; Hype

1983
Primary aldosteronism: diagnosis and differentiation of subtypes.
    Annals of internal medicine, 1984, Volume: 100, Issue:2

    Topics: Captopril; Diagnosis, Differential; Humans; Hyperaldosteronism; Metoclopramide; Renin-Angiotensin Sy

1984
Evidence for endogenous dopaminergic control of mineralocorticoids secretion in normal subjects and in patients with hyperaldosteronism.
    The Tohoku journal of experimental medicine, 1984, Volume: 144, Issue:1

    Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adult; Aldosterone; Desoxycorticosterone;

1984
Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism.
    Journal of steroid biochemistry, 1983, Volume: 19, Issue:5

    Topics: Adenoma; Adult; Female; Humans; Hyperaldosteronism; Kinetics; Male; Metoclopramide; Middle Aged; Min

1983
[The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism].
    Nihon Naibunpi Gakkai zasshi, 1984, Jan-20, Volume: 60, Issue:1

    Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adolescent; Adult; Aldosterone; Desoxycort

1984
Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic hyperaldosteronism.
    Klinische Wochenschrift, 1983, Jan-03, Volume: 61, Issue:1

    Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adenoma; Adrenal Cortex Neoplasms; Adult;

1983
Metoclopramide and secondary hyperaldosteronism.
    Annals of internal medicine, 1983, Volume: 98, Issue:6

    Topics: Humans; Hyperaldosteronism; Metoclopramide

1983
Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1981, Volume: 13, Issue:8

    Topics: Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Hypopituitarism; Metoclopramide; Prolactin;

1981
Hyper-responsiveness of aldosterone to metoclopramide in aldosteronism.
    Clinical endocrinology, 1982, Volume: 16, Issue:5

    Topics: Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Metoclopramide; Potassium; Pr

1982
Possible metoclopramide-induced increase in serum aldosterone in a premature infant.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Feb-01, Volume: 52, Issue:3

    Topics: Aldosterone; Gastroesophageal Reflux; Humans; Hyperaldosteronism; Infant; Infant, Newborn; Infant, P

1995
Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 78, Issue:2

    Topics: Adenoma; Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Dopamine; Female

1994
Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 77, Issue:4

    Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Chromatography

1993
Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
    Journal of hypertension, 1995, Volume: 13, Issue:10

    Topics: Aldosterone; Blood Pressure; Dihydroergotoxine; Dopamine Agonists; Dopamine Antagonists; Female; Hum

1995
Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2001, Volume: 100, Issue:9

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aldoster

2001
Adrenal sensitivity to angiotensin II and undiscovered aldosterone stimulating factors in hypertension.
    Journal of steroid biochemistry, 1979, Volume: 11, Issue:1C

    Topics: Adrenal Glands; Adult; Aldosterone; Dexamethasone; Female; Humans; Hyperaldosteronism; Hypertension;

1979
[Influence of endogenous renin-angiotensin system on plasma aldosterone responsiveness to metoclopramide].
    Nihon Naibunpi Gakkai zasshi, 1987, Feb-20, Volume: 63, Issue:2

    Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Diuretics; Dopamine; Female; Humans; Hyperaldostero

1987
Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1986, Volume: 18, Issue:2

    Topics: Adult; Aldosterone; Dopamine; Female; Humans; Hyperaldosteronism; Male; Metoclopramide; Middle Aged;

1986
Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Clinical science (London, England : 1979), 1985, Volume: 68, Issue:3

    Topics: 18-Hydroxycorticosterone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Corticosterone; Depres

1985
[The effects of metoclopramide and dopamine on aldosterone secretion in cultured adrenocortical adenoma cells and adjacent non-adenoma cells from patients with primary aldosteronism].
    Nihon Naibunpi Gakkai zasshi, 1985, Jun-20, Volume: 61, Issue:6

    Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aldosterone; Cells, Cultured; Chromatograp

1985